Related Experiment Video
Updated: May 1, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.2K
State-of-the-Art Theranostics of Thyroid Cancer
Michael C Kreissl1, Daniel A Hescheler1, Andreas Pfestroff2
1Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Magdeburg, Magdeburg, Leipziger Straße 44, 39120 Magdeburg, Germany.
PET Clinics
|April 29, 2026
Summary
Thyroid cancer theranostics have advanced with new radiopharmaceuticals targeting sodium-iodine in differentiated thyroid cancer. For aggressive subtypes, [18F]fluorodeoxyglucose PET/CT is standard, and somatostatin receptor agents are emerging options.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiopharmaceutical Therapy
Background:
- Thyroid cancer theranostics have seen significant advancements.
- Established and novel radiopharmaceuticals offer diverse treatment options.
- Sodium-iodine symporter remains a key target for differentiated thyroid cancer (DTC).
Purpose of the Study:
- To review the current landscape of thyroid cancer theranostics.
- To highlight the role of sodium-iodine targeting in DTC.
- To discuss advanced imaging and emerging theranostic approaches.
Main Methods:
- Review of established and novel radiopharmaceuticals for thyroid cancer.
- Discussion of diagnostic imaging modalities like [18F]fluorodeoxyglucose PET/CT.
- Exploration of theranostic strategies targeting somatostatin receptors.
Main Results:
- Sodium-iodine remains the primary target for differentiated thyroid cancer.
- [18F]fluorodeoxyglucose PET/CT is the gold standard for aggressive subtypes.
- Somatostatin receptor-targeted radiopharmaceuticals are emerging as viable options.
Conclusions:
- Thyroid cancer theranostics offer expanding therapeutic avenues.
- Personalized approaches utilizing specific molecular targets are crucial.
- Integration of novel radiopharmaceuticals enhances treatment efficacy.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
853
01:20Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
01:29Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
01:23The Thyroid Gland
7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
01:27Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28